Brief: Swedish Medical Products Agency Approves Subgroup Analysis In NextCell's ProTrans-Young Study
March 27 (Reuters) - NextCell Pharma AB NXTCL.ST :
* SWEDISH MEDICAL PRODUCTS AGENCY APPROVES SUBGROUP ANALYSIS
IN
NEXTCELL'S PROTRANS-YOUNG STUDY
Source text for Eikon: ID:nWkr898byy
Further company coverage: NXTCL.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on NextCell Pharma AB
See all newsBrief: NextCell Pharma Q1 Operating Income At SEK 2.8 Million
Brief: Nextcell Pharma Q4 Operating Income SEK 1.8 Mln
Brief: Nextcell Pharma Says ProTrans Data Show Insulin Production Preservation
Brief: NextCell Board Proposes Directed Issue Of 15,000,000 Shares
Brief: Nextcell Decides To Propose Directed Share Issue Of SEK 15 Mln